Digest Network Come funziona
Network
/
Società
Mi
Non verificato

MindWalk Holdings Corp.

Di cosa scriviamo

BiotecnologiaHIV, AIDS e malattie autoimmuniSaluteScienzaTecnica

21 comunicati stampa

Guarda tutti i comunicati
12/06/2026
Eventi
Scienza
Biotecnologia
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
10/06/2026
Industria
Information Technology
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
Farmaceutica
Biotecnologia
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
02/06/2026
Industria
Information Technology
Tecnica
Scienza
Software
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
27/05/2026
Industria
Scienza
Tecnica
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Sanità
Salute
MindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
18/05/2026
Scienza
Tecnica
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Biotecnologia
Farmaceutica
Salute
Analisi di mercato
Industria
The Biology Came First.
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
12/03/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Scienza
Biotecnologia
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
06/03/2026
Industria
Tecnica
Biotecnologia
Tecnologie Varie
Salute
Farmaceutica
Oncologia
Scienza
HIV, AIDS e malattie autoimmuni
Medicina - Varie
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
02/03/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Scienza
Biotecnologia
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
27/01/2026
Software
Scienza
Sanità
Hardware informatico
Farmaceutica
Tecnica
HIV, AIDS e malattie autoimmuni
Biotecnologia
Tecnologie Varie
Salute
Industria
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
14/01/2026
Scienza
Software
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
Industria
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0